GUIZHOU SANLI PHARMACEUTICAL CO.,LTD. revenue for the last year amounted to 1.64 B CNY, the most of which — 1.30 B CNY — came from its highest performing source at the moment, Respiratory System Medications. The greatest contribution to the revenue figure was made by China — last year it brought GUIZHOU SANLI PHARMACEUTICAL CO.,LTD. 1.63 B CNY, and the year before that — 1.20 B CNY.